Taylor Robichaux/LinkedIn
Jan 9, 2026, 07:07
Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
Taylor Robichaux, Emergency Medicine Clinical Pharmacist at Ochsner LSU Health, shared on LinkedIn:
”The landscape for cTTP is evolving!
Check out our paper on recombinant ADAMTS13 in JADPRO!
It was a privilege to work with such a great group of pharmacists.
Congratulations to all the authors!”
Read the full article here.
Article: Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura
Authors: Taylor Robichaux, Kathryn Dane, Christopher Parish, Justin Arnall, Donald Moore
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad AsherÖ‰ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang MiesbachÖ‰ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand